IDXX - IDEXX Laboratories, Inc. Stock Analysis | Stock Taper
Logo

About IDEXX Laboratories, Inc.

https://www.idexx.com

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments.

Jonathan J. Mazelsky

CEO

Jonathan J. Mazelsky

Compensation Summary
(Year 2024)

Salary $1,121,154
Stock Awards $5,199,755
Option Awards $5,200,032
Incentive Plan Pay $1,450,150
All Other Compensation $35,960
Total Compensation $13,007,051
Industry Medical - Diagnostics & Research
Sector Healthcare
Went public June 21, 1991
Method of going public IPO
Full time employees 11,000

Split Record

Date Type Ratio
2015-06-16 Forward 2:1
2007-11-27 Forward 2:1

ETFs Holding This Stock

Ratings Snapshot

Rating : B

Discounted Cash Flow 3
Return On Equity 5
Return On Assets 5
Debt To Equity 1
Price To Earnings 1
Price To Book 1
Overall Score 3

Most Recent Analyst Grades

Grade Summary

Buy 2
Outperform 1
Overweight 3
Neutral 3

Showing Top 6 of 9

Price Target

Target High $850
Target Low $750
Target Median $805
Target Consensus $803.57

Institutional Ownership

Summary

% Of Shares Owned 77.24%
Total Number Of Holders 1,637

Showing Top 3 of 1,637